Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events
Ishitsuka, Kantaro, Yokoyama, Yasuhisa, Baba, Naoko, Matsuoka, Ryota, Sakamoto, Noriaki, Sakamoto, Tatsuhiro, Kusakabe, Manabu, Kato, Takayasu, Kurita, Naoki, Nishikii, Hidekazu, Sakata-Yanagimoto, Mamiko, Obara, Naoshi, Hasegawa, Yuichi, Chiba, Shigeru
Published in Journal of Clinical and Experimental Hematopathology (01.01.2022)
Published in Journal of Clinical and Experimental Hematopathology (01.01.2022)
Get full text
Journal Article